Pietro Lampertico (P Lampertico)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 79

Top Topics

Genome Wide Association

Hepatitis B Virus

Prognostic Factors

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

Journal of viral hepatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Eloisa Franchi, Daniele Eliseo Dondossola, Giulia Maria Francesca Marini, Massimo Iavarone, Luca Del Prete, Clara Di Benedetto, Maria Francesca Donato, Barbara Antonelli, Pietro Lampertico, Lucio Caccamo
Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on Outcomes. Cancers 16 (5) (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Andrea Vecchi, Marzia Rossi, Camilla Tiezzi, Paola Fisicaro, Sara Doselli, Elena Adelina Gabor, Amalia Penna, Ilaria Montali, Camilla Ceccatelli Berti, Valentina Reverberi, Anna Montali, Simon P Fletcher, Elisabetta Degasperi, Dana Sambarino, Diletta Laccabue, Floriana Facchetti, Simona Schivazappa, Elisabetta Loggi, Barbara Coco, Daniela Cavallone, Elena Rosselli Del Turco, Marco Massari, Giuseppe Pedrazzi, Gabriele Missale, Gabriella Verucchi, Pietro Andreone, Maurizia Rossana Brunetto, Pietro Lampertico, Carlo Ferrari, Carolina Boni
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B. Gut (2024)
Micheli Laura, Alessandra Pacini, Di Cesare Mannelli Lorenzo, Elena Trallori, Roberta D'Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini
Correction: Micheli et al. Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation. Nutrients 2020, 12 , 1819. Nutrients 16 (13) (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Maria Paola Anolli, Sara Colonia Uceda Renteria, Elisabetta Degasperi, Marta Borghi, Floriana Facchetti, Dana Sambarino, Riccardo Perbellini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Micheli Laura, Alessandra Pacini, Di Cesare Mannelli Lorenzo, Elena Trallori, Roberta D'Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini
Correction: Micheli et al. Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation. Nutrients 2020, 12 , 1819. Nutrients 16 (13) (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics (2024)
Maria Paola Anolli, Sara Colonia Uceda Renteria, Elisabetta Degasperi, Marta Borghi, Floriana Facchetti, Dana Sambarino, Riccardo Perbellini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver international : official journal of the International Association for the Study of the Liver (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Eloisa Franchi, Daniele Eliseo Dondossola, Giulia Maria Francesca Marini, Massimo Iavarone, Luca Del Prete, Clara Di Benedetto, Maria Francesca Donato, Barbara Antonelli, Pietro Lampertico, Lucio Caccamo
Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on Outcomes. Cancers 16 (5) (2024)
Maria Paola Anolli, Sara Colonia Uceda Renteria, Elisabetta Degasperi, Marta Borghi, Floriana Facchetti, Dana Sambarino, Riccardo Perbellini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver (2024)
Elisa Farina, Alessandro Loglio, Giulia Tosetti, Elisabetta Degasperi, Mauro Viganò, Carmine Gentile, Sara Monico, Riccardo Perbellini, Marta Borghi, Floriana Facchetti, Sara Colonia Uceda Renteria, Ferruccio Ceriotti, Federica Cerini, Massimo Primignani, Pietro Lampertico
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years. Alimentary pharmacology & therapeutics (2023)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Bulevirtide-based treatment strategies for chronic hepatitis delta: A review. Journal of viral hepatitis (2023)
Serena Pelusi, Cristiana Bianco, Massimo Colombo, Giuliana Cologni, Paolo Del Poggio, Nicola Pugliese, Daniele Prati, Marie Graciella Pigozzi, Roberta D'Ambrosio, Pietro Lampertico, Stefano Fagiuoli, Luca Vittorio Valenti, null null
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals. Liver international : official journal of the International Association for the Study of the Liver (2023)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Bulevirtide-based treatment strategies for chronic hepatitis delta: A review. Journal of viral hepatitis (2023)
Marzia Rossi, Andrea Vecchi, Camilla Tiezzi, Valeria Barili, Paola Fisicaro, Amalia Penna, Ilaria Montali, Stephane Daffis, Simon P Fletcher, Anuj Gaggar, Jonathan Medley, Michael Graupe, Latesh Lad, Alessandro Loglio, Roberta Soffredini, Marta Borghi, Teresa Pollicino, Cristina Musolino, Arianna Alfieri, Federica Brillo, Diletta Laccabue, Marco Massari, Chiara Boarini, Gianluca Abbati, Giuseppe Pedrazzi, Gabriele Missale, Pietro Lampertico, Carlo Ferrari, Carolina Boni
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro. Gut (2023)
Barbara Testoni, Caroline Scholtès, Marie-Laure Plissonnier, Alexia Paturel, Françoise Berby, Floriana Facchetti, François Villeret, Elisabetta Degasperi, Beth Scott, Aaron Hamilton, Marintha Heil, Pietro Lampertico, Massimo Levrero, Fabien Zoulim
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B. Gut (2023)
Roberta D'Ambrosio, Sara Piccinelli, Benedetta Beccalli, Angiola Spinetti, Massimo Puoti, Stefano Fagiuoli, Carlo Federico Magni, Andrea Vavassori, Paolo Sacchi, Silvana Castaldi, Giulia Bombardieri, Claudio Farina, Sabrina Buoro, Alessandro Amorosi, Matteo Corradin, Danilo Cereda, Pietro Lampertico, null null
A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969-1989 birth-cohort. Liver international : official journal of the International Association for the Study of the Liver (2023)
Harry L A Janssen, Jin-Lin Hou, Asselah Tarik, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection. Gut (2023)
Benjamin Maasoumy, Pietro Lampertico
Hepatitis Delta: Ready for primetime? Liver international : official journal of the International Association for the Study of the Liver (2023)
Andrea Costantino, Letizia Corinna Morlacchi, Maria Francesca Donato, Andrea Gramegna, Elisa Farina, Clara Dibenedetto, Mariarosaria Campise, Matteo Redaelli, Marta Perego, Carlo Alfieri, Francesco Blasi, Pietro Lampertico, Evaldo Favi
Hesitancy toward the Full COVID-19 Vaccination among Kidney, Liver and Lung Transplant Recipients in Italy. Vaccines 10 (11) (2022)
Elisabetta Degasperi, Maria P Anolli, Pietro Lampertico
Bulevirtide for patients with compensated chronic hepatitis delta: A review. Liver international : official journal of the International Association for the Study of the Liver (2022)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies. Viruses 14 (11) (2022)
Roberta D'Ambrosio, Pietro Lampertico
Is it time to refine HCC surveillance strategies in HCV cured patients? Hepatology (Baltimore, Md.) 76 (1) (2022)
Young-Suk Lim, Wai Kay Seto, Masayuki Kurosaki, Scott Fung, Jia-Horng Kao, Jin-Lin Hou, Stuart C Gordon, John F Flaherty, Leland J Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data. Alimentary pharmacology & therapeutics 55 (8) (2022)
Jordan J Feld, Xavier Forns, Douglas E Dylla, Hiromitsu Kumada, Victor De Ledinghen, Lai Wei, Robert S Brown, Robert Flisiak, Pietro Lampertico, Dominique Thabut, Mark Bondin, Fernando Tatsch, Margaret Burroughs, John Marcinak, Zhenzhen Zhang, Amanda Emmett, Ira M Jacobson
Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts. Journal of viral hepatitis 29 (12) (2022)
Young Suk Lim, Pietro Lampertico
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B? Authors' reply. Alimentary pharmacology & therapeutics 55 (8) (2022)
Roberta D'Ambrosio, Giuliano Rizzardini, Massimo Puoti, Stefano Fagiuoli, Maria Paola Anolli, Claudia Gabiati, Federico D'Amico, Luisa Pasulo, Umberto Restelli, Massimo Colombo, Pietro Lampertico
Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination. Liver international : official journal of the International Association for the Study of the Liver 42 (5) (2022)
Elisabetta Degasperi, Roberta D'Ambrosio, Pietro Lampertico
Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting antivirals in terms of prediction of hepatocellular carcinoma-authors' reply. Alimentary pharmacology & therapeutics 55 (1) (2022)
Maurizia Rossana Brunetto, Ivana Carey, Benjamin Maasoumy, Cristina Marcos-Fosch, André Boonstra, Gian Paolo Caviglia, Alessandro Loglio, Daniela Cavallone, Caroline Scholtes, Gabriele Ricco, Antonina Smedile, Mar Riveiro-Barciela, Florian van Boemmel, Annemiek van der Eijk, Fabien Zoulim, Thomas Berg, Markus Cornberg, Pietro Lampertico, Kosh Agarwal, Maria Buti Ferret
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis. Alimentary pharmacology & therapeutics 53 (6) (2021)
Massimo Iavarone, Federica Invernizzi, Tommy Ivanics, Stefano Mazza, Claudio Zavaglia, Marco Sanduzzi-Zamparelli, Miguel López Fraile López, Carolin Czauderna, Giovanni Di Costanzo, Sherrie Bhoori, Matthias Pinter, Matteo Angelo Manini, Giuliana Amaddeo, Ainhoa Fernandez Yunquera, Federico Piñero, Maria Jose Blanco Rodríguez, Margarita Anders, Gabriel Aballay Soteras, Gerda Elisabeth Villadsen, Peter Daechul Yoon, Lucia Cesarini, Álvaro Díaz-González, Maria Luisa González-Diéguez, Raffaella Tortora, Arndt Weinmann, Vincenzo Mazzaferro, Mario Romero Cristóbal, Gonzalo Crespo, Helene Regnault, Massimo De Giorgio, Maria Varela, Rebecca Prince, Luigia Scudeller, Maria Francesca Donato, Marcus-Alexander Wörns, Jordi Bruix, Gonzalo Sapisochin, Pietro Lampertico, Maria Reig
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 27 (12) (2021)
Massimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, Paolo Del Poggio, Paolo Perini, Roberta D'Ambrosio, Elisabetta Degasperi, Clara Dibenedetto, Alessia Giorgini, Luisa Pasulo, Franco Maggiolo, Francesco Castelli, Paola Brambilla, Ombretta Spinelli, Tiziana Re, Ana Lleo, Mariagrazia Rumi, Caterina Uberti-Foppa, Alessandro Soria, Alessio Aghemo, Pietro Lampertico, Chiara Baiguera, Monica Schiavini, Stefano Fagiuoli, Raffaele Bruno, null null
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting. Journal of viral hepatitis 28 (3) (2021)
Stefania Varchetta, Dalila Mele, Roberta D'Ambrosio, Riccardo Perbellini, Andrea Lombardi, Angela Rojas, Stefania Paolucci, Fausto Baldanti, Barbara Oliviero, Stefania Mantovani, Carmine Tinelli, Annalisa De Silvestri, Manuel Romero, Pietro Lampertico, Mario Umberto Mondelli
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C. Journal of viral hepatitis 28 (10) (2021)
Elisabetta Degasperi, Riccardo Perbellini, Roberta D'Ambrosio, Sara Colonia Uceda Renteria, Ferruccio Ceriotti, Alberto Perego, Corinna Orsini, Marta Borghi, Massimo Iavarone, Mariangela Bruccoleri, Alessandro Rimondi, Annalisa De Silvestri, Angelo Sangiovanni, Pietro Lampertico
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents. Alimentary pharmacology & therapeutics (2021)
Pietro Lampertico, Georgios Papatheodoridis
Editorial: similar risk of hepatocellar carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Alimentary pharmacology & therapeutics 53 (5) (2021)
Massimo Iavarone, Barbara Antonelli, Anna Maria Ierardi, Matilde Topa, Angelo Sangiovanni, Andrea Gori, Chiara Oggioni, Giorgio Rossi, Gianpaolo Carrafiello, Pietro Lampertico
Reshape and secure HCC managing during COVID-19 pandemic: A single centre analysis of four periods in 2020 versus 2019. Liver international : official journal of the International Association for the Study of the Liver (2021)
Luca Vittorio Valenti, Serena Pelusi, Cristiana Bianco, Ferruccio Ceriotti, Alessandra Berzuini, Laura Iogna Prat, Roberta Trotti, Francesco Malvestiti, Roberta D'Ambrosio, Pietro Lampertico, Agostino Colli, Massimo Colombo, Emmanuel A Tsochatzis, Mirella Fraquelli, Daniele Prati
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update. Hepatology communications 5 (11) (2021)
Andrea Costantino, Federica Invernizzi, Erica Centorrino, Maurizio Vecchi, Pietro Lampertico, Maria Francesca Donato
COVID-19 Vaccine Acceptance among Liver Transplant Recipients. Vaccines 9 (11) (2021)
Stephan Urban, Christoph Neumann-Haefelin, Pietro Lampertico
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut 70 (9) (2021)
Gian Eugenio Tontini, Giovanni Aldinio, Nicoletta Nandi, Alessandro Rimondi, Dario Consonni, Massimo Iavarone, Paolo Cantù, Angelo Sangiovanni, Pietro Lampertico, Maurizio Vecchi
An Unprecedented Challenge: The North Italian Gastroenterologist Response to COVID-19. Journal of clinical medicine 11 (1) (2021)
Luca Vittorio Valenti, Serena Pelusi, Alessio Aghemo, Sara Gritti, Luisa Pasulo, Cristiana Bianco, Claudia Iegri, Giuliana Cologni, Elisabetta Degasperi, Roberta D'Ambrosio, Paolo Del Poggio, Alessandro Soria, Massimo Puoti, Isabella Carderi, Marie Graciella Pigozzi, Canio Carriero, Angiola Spinetti, Valentina Zuccaro, Massimo Memoli, Alessia Giorgini, Mauro Viganò, Maria Grazia Rumi, Tiziana Re, Ombretta Spinelli, Maria Chiara Colombo, Tiziana Quirino, Barbara Menzaghi, Gianpaolo Lorini, Angelo Pan, Antonella D'Arminio Monforte, Elisabetta Buscarini, Aldo Autolitano, Paolo Bonfanti, Natalia Terreni, Gianpiero Aimo, Monia Mendeni, Daniele Prati, Pietro Lampertico, Massimo Colombo, Stefano Fagiuoli, null null
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study. Hepatology communications (2021)
Pierpaolo Biondetti, Lorenzo Saggiante, Anna Maria Ierardi, Massimo Iavarone, Angelo Sangiovanni, Filippo Pesapane, Enrico Maria Fumarola, Pietro Lampertico, Gianpaolo Carrafiello
Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC. Cancers 13 (22) (2021)
Alkistis Papatheodoridi, Antonios Chatzigeorgiou, Lampros Chrysavgis, Panagiotis Lembessis, Alessandro Loglio, Floriana Facchetti, Evangelos Cholongitas, Michael Koutsilieris, Pietro Lampertico, Georgios Papatheodoridis
Circulating cell-free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients. Journal of viral hepatitis 28 (3) (2020)
Alessandro Loglio, Massimo Iavarone, Floriana Facchetti, Dhanai Di Paolo, Riccardo Perbellini, Giovanna Lunghi, Ferruccio Ceriotti, Claudio Galli, Maria T Sandri, Mauro Viganò, Angelo Sangiovanni, Massimo Colombo, Pietro Lampertico
The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy. Liver international : official journal of the International Association for the Study of the Liver 40 (8) (2020)
Thodoris Voulgaris, Margarita Papatheodoridi, Pietro Lampertico, Georgios Papatheodoridis
Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2020)
Alessandro Loglio, Pietro Lampertico
How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals? Hepatology communications 4 (1) (2020)
Pietro Lampertico, Thomas Berg, Maria Buti Ferret, Anita Pathil, Joerg Petersen, Stephen D Ryder, Fabien Zoulim, Irina Botros, John F Flaherty, Belinda Jump, Marjoleine L Op den Brouw, Anna van Troostenburg, Heribert Ramroth, null null
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study. Alimentary pharmacology & therapeutics 52 (3) (2020)
Elisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, Roberta D'Ambrosio, Roberta Soffredini, Marta Borghi, Riccardo Perbellini, Floriana Facchetti, Massimo Iavarone, Angelo Sangiovanni, Luca Vittorio Valenti, Pietro Lampertico
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs. Hepatology (Baltimore, Md.) 72 (6) (2020)
Maria Elisa Mancuso, Silvia Linari, Elena Santagostino, Dario Bartolozzi, Roberta D'Ambrosio, Marta Borghi, Pietro Lampertico, Flora Peyvandi, Giancarlo Castaman, Alessio Aghemo
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study. Liver international : official journal of the International Association for the Study of the Liver 40 (5) (2020)
Pietro Lampertico, Stefan Mauss, Marcello Persico, Stephen T Barclay, Steven Marx, Kristina Lohmann, Mark Bondin, ZhenZhen Zhang, Fiona Marra, Pamela S Belperio, Heiner Wedemeyer, Steven Flamm
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis. Advances in therapy 37 (9) (2020)
Alessandro Soria, Marco Fava, Davide P Bernasconi, Giuseppe Lapadula, Elisa Colella, Maria G Valsecchi, Guglielmo M Migliorino, Roberta D'Ambrosio, Simona Landonio, Monica Schiavini, Angiola Spinetti, Canio Carriero, Elisabetta Degasperi, Giuliana Cologni, Federico Gatti, Paolo Viganò, Hamid Hasson, Caterina Uberti-Foppa, Luisa Pasulo, Chiara Baiguera, Roberto Rossotti, Maria Vinci, Massimo Puoti, Alessia Giorgini, Barbara Menzaghi, Andrea Lombardi, Angelo Pan, Alessio Aghemo, Paolo A Grossi, Roberto Boldizzoni, Silvia Colombo, Mauro Viganò, Maria G Rumi, Paolo Del Poggio, Luca Vittorio Valenti, Omar Giglio, Anna De Bona, Antonella d'Arminio Monforte, Alberto Colombo, Ombretta Spinelli, Marie G Pigozzi, Chiara Molteni, Paolo Bonfanti, Natalia Terreni, Paolo Perini, Andrea Capretti, Daniele Bella, Cecilia Liani, Silvia Polo, Gianpiero Aimo, Layla Pagnucco, Sherrie Bhoori, Riccardo Centenaro, Massimo Graffeo, Antonio Ciaccio, Elena Dionigi, Sergio Lazzaroni, Isabella Carderi, Mariella Di Marco, Giuliano Rizzardini, Franco Noventa, Pietro Lampertico, Stefano Fagiuoli
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2020)
Alessandra Mangia, Scott Milligan, Mandana Khalili, Stefano Fagiuoli, Stephen D Shafran, Fabrice Carrat, Denis Ouzan, Georgios Papatheodoridis, Alnoor Ramji, Sergio M Borgia, Heiner Wedemeyer, Ruggero Losappio, Francisco Pérez-Hernandez, Nicole Wick, Robert S Brown, Pietro Lampertico, Karen Doucette, Ioanna Ntalla, Heribert Ramroth, Michael Mertens, Kim Vanstraelen, Juan Turnes
Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts. Liver international : official journal of the International Association for the Study of the Liver 40 (8) (2020)
Massimo Iavarone, Roberta D'Ambrosio, Pietro Lampertico
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19. Gut 70 (9) (2020)
Alessandro Loglio, Massimo Iavarone, Mauro Viganò, Annalisa Orenti, Floriana Facchetti, Ivan Cortinovis, Giovanna Lunghi, Ferruccio Ceriotti, Vincenzo Occhipinti, Mariagrazia Rumi, Angelo Sangiovanni, Massimo Colombo, Pietro Lampertico
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy. Liver international : official journal of the International Association for the Study of the Liver 39 (10) (2019)
Lai Wei, Vedran Pavlovic, Aruna T Bansal, Xiaoping Chen, Graham R Foster, Hua He, Jia-Horng Kao, Pietro Lampertico, Yun-Fan Liaw, Adriana Motoc, Georgios Papatheodoridis, Teerha Piratvisuth, Robert Plesniak, Cynthia Wat
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B. Journal of viral hepatitis 26 (9) (2019)
Mauro Viganò, Glenda Grossi, Alessandro Loglio, Pietro Lampertico
Treatment of hepatitis B: Is there still a role for interferon? Liver international : official journal of the International Association for the Study of the Liver (2019)
Mauro Viganò, Alessandro Loglio, Sara Labanca, Serena Zaltron, Francesco Castelli, Pietro Andreone, Vincenzo Messina, Roberto Ganga, Nicola Coppola, Aldo Marrone, Maurizio Russello, Alfredo Marzano, Alessandra Tucci, Gloria Taliani, Massimo Fasano, Stefano Fagiuoli, Erica Villa, Fabrizio Bronte, Teresa Santantonio, Giuseppina Brancaccio, Vincenzo Occhipinti, Floriana Facchetti, Glenda Grossi, Mariagrazia Rumi, Pietro Lampertico
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir. Liver international : official journal of the International Association for the Study of the Liver 39 (3) (2019)
Alessandro Loglio, Simone Segato, Pietro Lampertico
Hepatitis D - how is the fight against this foe going? Expert review of clinical pharmacology 12 (3) (2019)
Stefan Zeuzem, Stefan Bourgeois, Susan Greenbloom, Maria Buti, Alessio Aghemo, Pietro Lampertico, Ewa Janczewska, Seng Gee Lim, Christophe Moreno, Peter Buggisch, Edward Tam, Chris Corbett, Wouter Willems, Leen Vijgen, Bart Fevery, Sivi Ouwerkerk-Mahadevan, Oliver Ackaert, Maria Beumont, Ronald Kalmeijer, Rekha Sinha, Michael Biermer, null null
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1. Hepatology (Baltimore, Md.) 69 (6) (2019)
Elisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, Elisa Farina, Roberta D'Ambrosio, Roberta Soffredini, Massimo Iavarone, Pietro Lampertico
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals. Journal of viral hepatitis 26 (10) (2019)
Paolo Cantù, Ilaria Tarantino, Anna Baldan, Massimiliano Mutignani, Andrea Tringali, Giovanni Lombardi, Angelo Cerofolini, Antonio Di Sario, Giorgia Catalano, Helga Bertani, Davide Ghinolfi, Valentina Boarino, Enzo Masci, Milutin Bulajic, Antonio Pisani, Alberto Fantin, Dario Ligresti, Luca Barresi, Mario Traina, Paolo Ravelli, Edoardo Forti, Federico Barbaro, Guido Costamagna, Luca Rodella, Luca Maroni, Mauro Salizzoni, Rita Conigliaro, Franco Filipponi, Alberto Merighi, Teresa Staiano, Michela Monteleone, Vincenzo Mazzaferro, Elena Zucchi, Maurizio Zilli, Elena Nadal, Roberto Rosa, Giulio Santi, Ilaria Parzanese, Luciano De Carlis, Maria Francesca Donato, Pietro Lampertico, Umberto Maggi, Lucio Caccamo, Giorgio Rossi, Maurizio Vecchi, Roberto Penagini
Endo-therapies for biliary duct-to-duct anastomotic stricture after liver transplantation: Outcomes of a nationwide survey. Liver international : official journal of the International Association for the Study of the Liver 39 (7) (2019)
Giordano Sigon, Roberta D'Ambrosio, Mariagrazia Clerici, Giuseppina Pisano, Veena Chantarangkul, Roberta Sollazzi, Rosa Lombardi, Flora Peyvandi, Pietro Lampertico, Silvia Fargion, Armando Tripodi, Anna Ludovica Fracanzani
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis. Liver international : official journal of the International Association for the Study of the Liver 39 (12) (2019)
Henry Lik Yuen Chan, D Messinger, Georgios Papatheodoridis, Markus Cornberg, Q Xie, T Piratvisuth, H Ren, P T Kennedy, A Thompson, A Caputo, G Bakalos, Vedran Pavlovic, Pietro Lampertico
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 48 (5) (2018)
Angelo Sangiovanni, Michela Triolo, Massimo Iavarone, Laura V Forzenigo, Antonio Nicolini, Giorgio Rossi, Vincenzo la Mura, Massimo Colombo, Pietro Lampertico
Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations. Liver international : official journal of the International Association for the Study of the Liver 38 (9) (2018)
Loreta Anesti Kondili, Sarah Robbins Scott, Sarah Blach, Ivane Gamkrelidze, Anna Linda Zignego, Maurizia R Brunetto, Giovanni Raimondo, Gloria Taliani, Andrea Iannone, Francesco P Russo, Teresa A Santantonio, Massimo Zuin, Luchino Chessa, Pierluigi Blanc, Massimo Puoti, Maria Vinci, Elke M Erne, Mario Strazzabosco, Marco Massari, Pietro Lampertico, Maria G Rumi, Alessandro Federico, Alessandra Orlandini, Alessia Ciancio, Guglielmo Borgia, Pietro Andreone, Nicola Caporaso, Marcello Persico, Donatella Ieluzzi, Salvatore Madonia, Andrea Gori, Antonio Gasbarrini, Carmine Coppola, Giuseppina Brancaccio, Angelo Andriulli, Maria Giovanna Quaranta, Simona Montilla, Homie Razavi, Mario Melazzini, Stefano Vella, Loreta A Kondili, null null
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? Liver international : official journal of the International Association for the Study of the Liver 38 (12) (2018)
R El Sharkawy, K Thabet, Pietro Lampertico, S Petta, Alessandra Mangia, T Berg, M Metwally, A Bayoumi, A Boonstra, Willem Pieter Brouwer, A Smedile, M L Abate, A Loglio, M W Douglas, A Khan, R Santoro, J Fischer, D J Leeming, C Liddle, Jacob George, M Eslam
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 48 (5) (2018)
Pietro Lampertico, Maurizia R Brunetto, Antonio Craxì, Giovanni B Gaeta, Mario Rizzetto, Antonella Rozzi, Massimo Colombo, null null
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. Journal of viral hepatitis 26 (1) (2018)
Alessandro Loglio, Massimo Iavarone, G Grossi, M Viganò, Maria Grazia Rumi, F Facchetti, Giovanna Lunghi, A Sangiovanni, M Colombo, Pietro Lampertico
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B. Alimentary pharmacology & therapeutics 48 (4) (2018)
Pietro Lampertico, Thomas Berg
Less can be more: A finite treatment approach for HBeAg-negative chronic hepatitis B. Hepatology (Baltimore, Md.) 68 (2) (2018)
M Persico, Andrea Aglitti, Alessio Aghemo, M Rendina, A Lleo, A Ciancio, Vito Di Marco, Pietro Lampertico, M R Brunetto, M Zuin, Pietro Andreone, E Villa, G Troshina, Vincenza Calvaruso, E Degasperi, B Coco, A Giorgini, F Conti, Alfredo Di Leo, L Marzi, V Boccaccio, S Bollani, P Maisonneuve, Savino Bruno
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma. Alimentary pharmacology & therapeutics 47 (12) (2018)
Roberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, Elisabetta Degasperi, Angelo Sangiovanni, Marco Maggioni, Mirella Fraquelli, Riccardo Perbellini, William Rosenberg, Pierre Bedossa, Massimo Colombo, Pietro Lampertico
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression. Liver international : official journal of the International Association for the Study of the Liver 38 (8) (2018)
Enrico Galmozzi, Floriana Facchetti, Glenda Grossi, Alessandro Loglio, Mauro Viganò, Giovanna Lunghi, Massimo Colombo, Pietro Lampertico
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients. Liver international : official journal of the International Association for the Study of the Liver 38 (3) (2017)
R D'Ambrosio, Pietro Lampertico
Editorial: good news to patients with thalassaemia-HCV clearance made easy with direct-acting antivirals. Alimentary pharmacology & therapeutics 46 (6) (2017)